Is Now the Time to Invest in Cleveland BioLabs Inc. (NASDAQ:CBLI)?

Is Now the Time to Invest in Cleveland BioLabs Inc. (NASDAQ:CBLI)?

SHARE

The Cleveland BioLabs Inc. (CBLI) shares are trading at lower $2.45.

To add more color to this target, the company’s high over the last year is $5.00 and the low is $0.50. Over the last 52 weeks, CBLI is down -51.00% while the S&P 500 is up 1.47%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, CBLI reported a profit of $0.6 million. Cleveland BioLabs Inc. also saw revenues increase to $0.16 million. In addition, CBLI has free cash flow of -$0.43 million as of 03-2020 The company’s EBITDA came in at -$0.44 million which compares well with its peers.

CBLI Return on Equity (ROE) is 63.00%, and its Return on Assets is -102.50%. All told, it is clear that, CBLI needs to be on your watchlist.

Find out when CBLI reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. CBLI has a short ratio of 0.01 and outstanding shares of 11.35M.

Company Outlook

CBLI has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 9.99 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.21. Cleveland BioLabs Inc. CBLI also noted assets of $1.86 million at the end of the last quarter. Investors should also keep an eye on sector updates as CBLI has historically followed its peers on positive news.

All told, Cleveland BioLabs Inc. CBLI has strung together solid data and demonstrated underlying fundamentals. At its current valuation, CBLI represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Cleveland BioLabs Inc. CBLI is now commanding a market cap of 12.76M and a float of 5.58M. CBLI is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of CBLI stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in CBLI, either long or short, and we have not been compensated for this article.